KEY FEATURES OF LINPLANT®
Better regulated blood glucose Implants last about a month Eliminates daily blood sampling May eliminate daily insulin injections

Insulin Implants - Free for Diabetic Research and Abandoned Cats

ABOUT LINPLANT®

Linplant®, a product of LinShin Canada, Inc., is a sustained release insulin preparation developed at the University of Toronto for diabetic research animals and now used in laboratories worldwide. Each implant, containing only natural materials and slightly smaller than the size of the microchip implant, used for identification in cats and dogs, releases 2 IU of insulin each day per implant for about a month. The implant is subsequently absorbed by the surrounding tissues of the host body without any ill-effects.

HERE'S PEPPER

Pepper, a cat used in sleep science research at a University, developed insulin dependent diabetes mellitus. For 2 years she was successfully managed with twice daily injections of insulin. She eventually became unregulated despite repeated blood glucose curves, adjustments of the insulin dose, and meal timing. Within 2 months, Pepper became refractory to exogenous insulin injection, began to show poor appetite, vomiting, weight loss and had 4 episodes of ketoacidosis requiring intravenous fluids and constant rate infusion of regular insulin. Euthanasia was considered. Fortunately, the resident staff veterinarian had read about a sustained release insulin implant being used with good results at the Department of Pharmaceutical Sciences at the University. She called the implant supplier in Toronto and decided to use the sustained release insulin implant. Within a few weeks, Pepper had improved dramatically. She regained her appetite and began showing play behaviour again. After stabilizing on the implant, she did not require any additional insulin injections. She has since been on implant therapy for over a year with excellent health.